期刊文献+

EB病毒融合基因重组BCG穿梭质粒的构建与鉴定 被引量:4

Construction and identification of recombinant shuttle-plasmid pMVZ2A
原文传递
导出
摘要 目的构建分泌性表达EB病毒融合基因Z2A的卡介苗(BCG)重组质粒。方法分别以BCG和EB病毒融合基因cDNA为模板,通过PCR扩增得到139 bp的BCG-Ag85B信号肽序列和2291 bp的Z2A基因序列。将BCG-Ag85B信号肽序列与大肠埃希菌-BCG穿梭表达载体pMV261重组,得到重组质粒pMVS。再将EB病毒融合基因序列Z2A亚克隆至pMVS中,得到重组质粒pMVZ2A。结果构建的重组质粒pMVZ2A经双酶切、PCR扩增及测序鉴定证实,克隆基因BCG-Ag85B信号肽和Z2A正确插入载体pMV261。结论重组质粒pMVZ2A可望在BCG中分泌性表达,该质粒的构建成功为改造BCG、发展新型抗EB病毒疫苗奠定了基础。 Objective To construct a recombinant secretory plasmid of Bacillus Calmette-Guerin(BCG) Ag85B-fused LMP2A and BZLF1.Methods The BCG Ag85B signal sequence and Z2A gene were amplified from the genome of BCG and Z2A by PCR,respectively.The BCG Ag85B signal sequence was cloned in E.coli-BCG shuttle-vector pMV261 to obtain pMVS.Then,a new recombinant plasmid,pMVZ2A,was constructed by inserting the Z2A gene into pMVS.Results The cloned genes BCG Ag85B and Z2A were correctly inserted into the vector pMV261,and this was confirmed by restriction endonuclease digestion and PCR amplification of Z2A and gene sequencing,respectively.Conclusion pMVZ2A should secretively express Z2A in BCG.This study provides the basis for further studies on the development of new EB virus vaccines and reconstruction of BCG.
出处 《中国病原生物学杂志》 CSCD 2009年第12期887-889,916,共4页 Journal of Pathogen Biology
基金 山东省卫生厅基金项目(No.2007HW035) 济宁医学院青年基金项目(No.081229)。
关键词 卡介苗 融合基因Z2A 基因重组 PCR BCG recombinant Z2A gene recombination PCR
  • 相关文献

参考文献9

  • 1PortisT, LongneekerR. Epstein-Barrvirus(EBV) LMPZA alters normal transeriptional regulation followingB-cell receptor activation[J]. Virology, 2004,318 : 524-- 533.
  • 2O'Donnell MA, Aldovini A,Duba R, et at. Recombinant Mycobacterium boris BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes[J]. Infect Immun, 1994,62:2508-2514.
  • 3Sambrook KJ,Fritisch EF, Maniatis T. Molecular cloning laboratory manual[M]. 2nd. New York:Cold Sping Harbour Laboratory Press, 1989.
  • 4朱伟,徐爱晶,罗兵.EB病毒LMP2A和EB病毒BZLF1融合基因反转录病毒表达载体的构建[J].中国组织工程研究与临床康复,2007,11(50):10109-10112. 被引量:3
  • 5Luo Y, Yamada H,Chen X, et al. Recombinant Mycobacteriurn bovisbacillus Calmette-Guerin (BCG) expressing mouse IL 18 augments Thl immunity and macrophage cytotoxicity[J]. Clin Exp Immunol,2004,137(1) :24--34.
  • 6Yamada H ,Kuroda E, Matsumoto S, et al. Prostaglandin E2downregulates viable Bacille Calmette-Guerininduced macrophage cytotoxicity against murine bladder cancer cell MBT-2 in vitro [J]. Clin Exp Immunol,2002,128(1) :52--58.
  • 7Redchenko IV, Rickinson AB. Accessing epstein-barr virus specific T-cell memory with pep tide-loaded dendritic cells[J]. J Virol, 1999,73 : 3342- 3421.
  • 8Murray RJ,Kurilla MG,Brooks J M. Identification of target antigens for the human cytotoxic T-cell response to epstein-barr virus ( EBV):implications for the immune control of EBV2 positive [J]. Malignanciesl Exp Med, 1992,176 :1572-- 1681.
  • 9Konishi K,Maruo S, Kato H, et al. Role of epstein-barr virus encoded latent membrane protein 2A on virus induced immortalization and virus activationl [J]. Gen Virol, 2001,82 : 14512-- 61.

二级参考文献20

  • 1李忠,杨柳,陈光兴,林炎水,段小军.绿色荧光蛋白在组织工程关节软骨构建中的示踪作用[J].中国临床康复,2005,9(30):84-86. 被引量:4
  • 2萨姆布鲁克 J,拉塞尔 D W.分子克隆实验指南[M].3版.黄培堂,王嘉玺,朱厚础,等译.北京:科学出版社,2002:96—99;1232—1236.
  • 3Iwakid D,Takada K. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol 2004; 172:1561-1566.
  • 4Lee SP, Tiemey R J, Thomas WA, et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol 1997; 158(7):3325-3334.
  • 5Schaadt E, Baier B, Mautner J, et al. Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation. J Gen Virol 2005;86 (Pt 3):551-559.
  • 6Speck P, Kline KA, Cheresh P, et al. Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus. J Gen Virol 1999;80 (Pt 8):2193.
  • 7Lu J, Lin WH, Chen SY, et al. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006,281 (13):8806-8814.
  • 8Portis T, Longecker R. Epstein-Barr virus ( EBV)LMP2A alters normal t ranscriptional regulation following B-cell receptor activation.Virology 2004; 318:524-533.
  • 9Kato K, Yokoyama A, Tohya Y, et al. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine 35 that regulates its coactivator function. J Gen Virol 2003; 84 ( Pt 12) :3381-3392.
  • 10Igarashi M, Kawaguchi Y, Hirai K, et al. Physical interaction of Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) with human oestrogen-related receptor 1 (hERR1): hERR1 interacts with a conserved domain of EBNA-LP that is critical for EBV-induced B-cell immortalization. J Gen Virol 2003;84:319-327.

共引文献2

同被引文献10

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部